drugset / Trial / NCT00966901

Photoirritation and Photoallergic Potential of a New Nicotine Patch

NCT00966901 ↗

Phase 1 Completed 43 enrolled McNeil AB
RandomizedSingle-groupDouble-blindScreening

Summary

An evaluation of the effects of UV exposure following the use of a new nicotine patch.

Timeline

Start
2005-08
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Patch Unknown 25 mg Other

Indications

No indication recorded.